Diagnostic potential of exosomal extracellular vesicles in oncology.
BMC cancer · 2024 · 56 citations · Marco Ruiz
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update.
Non-coding RNA · 2023 · 74 citations · Gabriel Lopez-Berestein
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside.
Cancers · 2024 · 46 citations · Gabriel Lopez-Berestein
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy.
NPJ precision oncology · 2024 · 33 citations · Gabriel Lopez-Berestein
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity.
Journal of the American Chemical Society · 2021 · 58 citations · Gabriel Lopez-Berestein
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
Nature communications · 2023 · 38 citations · Gabriel Lopez-Berestein
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges.
Cancers · 2023 · 25 citations · Gabriel Lopez-Berestein
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.
The Journal of clinical investigation · 2023 · 27 citations · Gabriel Lopez-Berestein